Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8382 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8267 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8194 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8088 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7852 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7755 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD8313 |
Approved |
0.756 |
Intermediate Similarity |
NPD8312 |
Approved |
0.755 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7432 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7431 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7355 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD411 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7313 |
Intermediate Similarity |
NPD74 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7285 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6273 |
Approved |
0.726 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD943 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7239 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7239 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7226 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7172 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD164 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7107 |
Intermediate Similarity |
NPD920 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD520 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD1511 |
Approved |
0.702 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7007 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7 |
Intermediate Similarity |
NPD5951 |
Approved |
0.6995 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD37 |
Approved |
0.6993 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6985 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD7635 |
Approved |
0.6971 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.697 |
Remote Similarity |
NPD4965 |
Approved |
0.697 |
Remote Similarity |
NPD4966 |
Approved |
0.6968 |
Remote Similarity |
NPD5762 |
Approved |
0.6968 |
Remote Similarity |
NPD5763 |
Approved |
0.6966 |
Remote Similarity |
NPD1281 |
Approved |
0.6966 |
Remote Similarity |
NPD1611 |
Approved |
0.6962 |
Remote Similarity |
NPD7236 |
Approved |
0.6959 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD17 |
Approved |
0.694 |
Remote Similarity |
NPD9261 |
Approved |
0.6939 |
Remote Similarity |
NPD6696 |
Suspended |
0.6939 |
Remote Similarity |
NPD1876 |
Approved |
0.6937 |
Remote Similarity |
NPD1512 |
Approved |
0.6928 |
Remote Similarity |
NPD6651 |
Approved |
0.6919 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6913
|
Remote Similarity |
NPD2861 |
Phase 2 |